Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04594772 · ClinicalTrials.gov registry record · Phase 2

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

A Phase 2 study of Pancreas Cancer, sponsored by University of Cincinnati.

Active
Registry status
Phase 2
Development phase
32
Enrollment target
2
Study locations

NCT04594772 is a Phase 2 study of Pancreas Cancer that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 32 participants, below the 907-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04594772, a Phase 2 study of Pancreas Cancer, is active but no longer recruiting, sponsored by University of Cincinnati.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
32 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine if neoadjuvant therapy to increases resection rate for pancreatic adenocarcinoma.

Conditions Studied

Pancreas Cancer

Interventions

  • DRUG Gemcitabine
  • PROCEDURE Pancreatectomy
  • DRUG Folfirinox
  • RADIATION radiation therapy

Study Locations (2)

Arizona

  • University of Arizona - Tucson

Ohio

  • University of Cincinnati Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2021-03-17
Est. Completion 2026-01-01
Phase Phase 2

Sponsor

University of Cincinnati

245 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04594772

The ClinicalTrials.gov registry entry for NCT04594772 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 907-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (96% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreas Cancer appearing as the primary indexed condition, and to 4 interventions - of which Gemcitabine is the first listed.

NCT04594772 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Ohio.

Frequently Asked Questions

What is clinical trial NCT04594772 about?

NCT04594772 is a clinical study titled "Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma". The purpose of this study is to determine if neoadjuvant therapy to increases resection rate for pancreatic adenocarcinoma.

What is the current status of trial NCT04594772?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2021-03-17. Estimated completion is 2026-01-01.

What conditions does trial NCT04594772 study?

This clinical trial studies the following conditions: Pancreas Cancer.

What interventions are being tested in trial NCT04594772?

The interventions under investigation include: Gemcitabine (DRUG), Pancreatectomy (PROCEDURE), Folfirinox (DRUG), radiation therapy (RADIATION).

Who is sponsoring clinical trial NCT04594772?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04594772 being conducted?

This trial has 2 study locations across Arizona, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pancreas Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pancreas Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.